The complexity of mitogen-activated protein kinases (MAPKs) made simple
1Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai 400085, India. malini@barc.gov.in
Cellular and Molecular Life Sciences : CMLS
|August 1, 2008
Summary
Mitogen-activated protein kinase (MAPK) pathways regulate cell growth, differentiation, and death. This review explores the specificity of the three main MAPK pathways: ERK, p38, and JNK.
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- Mitogen-activated protein kinase (MAPK) pathways are crucial signaling cascades involved in fundamental cellular processes.
- These pathways, including ERK, p38, and JNK, exhibit significant cross-talk but maintain specific functions.
- Understanding MAPK pathway specificity is key to deciphering cellular responses.
Purpose of the Study:
- To review the distinct roles and mechanisms of specificity within the three major MAPK pathways: ERK, p38, and JNK.
- To elucidate how these pathways achieve precise cellular outcomes despite extensive crosstalk.
- To provide a comprehensive overview of MAPK pathway regulation and function.
Main Methods:
- Literature review of existing research on MAPK pathways.
- Analysis of studies focusing on ERK, p38, and JNK signaling.
- Synthesis of information regarding pathway activation, components, and downstream effects.
Main Results:
- MAPK pathways (ERK, p38, JNK) are involved in cell growth, differentiation, and apoptosis.
- Specificity in MAPK signaling is achieved through various mechanisms, including scaffold proteins and feedback loops.
- Despite complex interactions, each pathway elicits distinct cellular responses.
Conclusions:
- The specificity of ERK, p38, and JNK pathways is essential for normal cellular function and response.
- Further research into MAPK pathway regulation can reveal therapeutic targets for diseases involving aberrant cell signaling.
- This review consolidates current knowledge on MAPK pathway specificity, highlighting areas for future investigation.
Related Concept Videos
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...